Prof. Dr. Süleyman ALICI Medikal Onkoloji

Bachelor’s: Atatürk University Faculty of Medicine

Specialization: Selçuk University Faculty of Medicine (Internal Medicine)

Subspecialty: Istanbul University Istanbul Faculty of Medicine (Medical Oncology)

Assistant Professorship: Yüzüncü Yıl University Faculty of Medicine

Associate Professorship: Yüzüncü Yıl University Faculty of Medicine

Professorship: Bahçeşehir University Faculty of Medicine

INSTITUTIONS HE HAS STUDIED AND WORKED AT
Selçuk University Faculty of Medicine Department of Internal Medicine
Yüzüncü Yıl University Faculty of Medicine Department of Internal Medicine
TC. Ministry of Health Ankara Atatürk Training & Research Hospital Medical Oncology Clinic
Dana Farber Cancer Institute, Boston – USA
Private Göztepe Medicalpark Hospital Cancer Hospital
Bahçeşehir University Faculty of Medicine Medicalpark Göztepe Hospital
Acıbadem Hospital

Medical Oncology

Turkish Medical Oncology Society – 1998

European Society of Medical Oncology (ESMO) – 1999

Turkish Oncology Group 2000

American Society of Clinical Oncology (ASCO) – 2000

Lung Cancer Society – 2003

Clinical Oncology Society (Founding Member)

International peer-reviewed articles published A1-50:

A1. Demir MK, Fakir E, Furuncuoglu Y, Alıcı S, Argon A, Koca S. Synovial sarcoma with multiple vertebrae metastases causing multilevel thoracic spinal cord compressions.

Spine J. 2016 Jun;16(6):e363-4. doi: 10.1016/j.spinee.2015.11.063. Epub 2015 Dec 8. No abstract available.

A2. Cirak Y, Furuncuoglu Y, Yapicier O, Alici S, Argon A. Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.

Int J Clin Exp Pathol. 2015 May 1;8(5):5345-53. eCollection 2015.

A3. Alici O, Kavakli HS, Koca C, Altintas ND, Aydin M, Alici S. Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats.

Mediators Inflamm. 2015;2015:810948. doi: 10.1155/2015/810948. Epub 2015 Apr 8.

A4. Unal OU, Oztop I, Yazici O, Ozatli T, Inal A, Günaydın Y, Alici S, Demirci U, Cinkir HY, Aktas B, Aslan K, Uncu D, Yilmaz AU, Oksuzoglu B, Buyukberber S. Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO). Oncol Res Treat. 2014;37(6):332-8.

A5. Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Cınkır HY, Alıcı S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan A. Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian society of medical oncology). Int Surg. 2014 Jan-Feb;99(1):2-7

A6. Oven Ustaalioglu BB, Unal OU, Turan N, Bilici A, Kaya S, Eren T, Ulas A, Inal A, Berk V, Demirci U, Alici S, Bal O, Benekli M, Gumus M. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences. Asian Pac J Cancer Prev. 2013;14(11):6287-92.

A7. Yetisyigit T, Arpaci E, Seber ES, Kucukoner M, Kos FT, Sonmez OU, Alici S, Akman T, Aktas B, Yildiz R, Gunaydin Y, Inanc M, Demirci U, Alkis N, Gumus M. Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncology. Asian Pac J Cancer Prev. 2013;14(9):5185-8.

A8. Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Suner A, Cınkır HY, Alıcı S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan A. Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical Oncology. Ann Ital Chir. 2013 Mar-Apr;84(2):143-8.

A9. Inal A, Akman T, Yaman S, Demir Ozturk S, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Yesil Cinkir H, Alici S, Uysal Sonmez O, Goksel G, Gokoz Dogu G, Umit Unal O, Tamozlu T, Buyukberber S, Melih Boruban C, Isikdogan A. Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology). J BUON. 2013 Jan-Mar;18(1):64-9.

A10. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Akman T, Coskun U, Sener N, Inanc M, Elkiran ET, Ozdemir NY, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Oksuzoglu B, Urakci Z. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. Breast Cancer. 2014 Nov;21(6):677-83.

A11. Baykara M, Ozturk SC, Buyukberber S, Helvaci K, Ozdemir N, Alkis N, Berk V, Koca D, Coskun U, Oksuzoglu B, Uncu D, Arpaci E, Ustaalioglu BO, Demirci U, Kucukoner M, Dogu GG, Alici S, Akman T, Ozkan M, Aslan UY, Durnali AG, Benekli M. Clinicopathological features in bilateral breast cancer.

Asian Pac J Cancer Prev. 2012;13(9):4571-5.

A12. Alici S, Buyukberber S, Alkis N, Benekli M, Ozkan M, Bilici A, Demirci U, Karaca H, Arpaci E, Gumus M, Altunbas M, Dane F, Turk HM; Anatolian Society of Medical Oncology. Low-dose docetaxel/cisplatin – leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma. Asian Pac J Cancer Prev. 2013;14(1):423-7.

A13. Kaya AO, Coskun U, Ozkan M, Sevinc A, Yilmaz AU, Gumus M, Unal OU, Ozdemir NY, Alici S, Berk V, Degerli H, Oner MK, Ozturk C, Kefeli U, Camcı C; Anatolian Society of Medical Oncology (ASMO). Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. Onkologie. 2012;35(10):576-80.

A14. Altinbas M, Kalender ME, Oven B, Sevinc A, Karaca H, Kaplan MA, Alici S, Arpaci E, Yildiz R, Uncu D, Camci C, Gumus M. Weekly topotecan for recurrent small cell lung cancer – a retrospective Anatolian Medical Oncology Group study. Asian Pac J Cancer Prev. 2012;13(6):2909-12.

A15. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Unal OU, Mert AG, Bilici M, Ozkan M, Elkiran ET, Yaman S, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Urakci Z, Buyukberber S. Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology). Oncology. 2012;83(3):141-50.

A16. Kaya AO, Buyukberber S, Ozkan M, Alkis N, Sevinc A, Ozdemir NY, Alici S, Esbah O, Berk V, Camci C, Ulas A, Coskun U, Benekli M. Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma. Asian Pac J Cancer Prev. 2012;13(2):463-7.SCI-E

A17. Yildiz R, Kalender ME, Dane F, Sevinc A, Gumus M, Camci C, Alici S, Kaya AO, Yaman E, Ozturk B, Coskun U, Benekli M, Uncu D, Buyukberber S. Docetaxel combined with oral etoposide as second line treatment for advanced gastric carcinoma after failure of platinun and fluoropyrimidine based regimens. J Oncol Pharm Pract,16(3): 173-8, 2010.SCI-E

A18. Kiymaz N, Yılmaz N, Kösem M, Yazıcı T, Alici S, Kozan A. Cerebral leptomeningeal metastasis in a case of primary ovarian lymphoma. J Cancer Res and Exper Oncol, 2(2):19-22, 2010

SCI-E

A19. Coskun U, Kaya AO, Alkis N, Buyukberber S, Alici S, Celenkoglu G, Uncu D, Ozkan M, Sevinc A, Benekli M. UFT plus oral folinic acid with alternating oral and intravenous vinoralbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Oncologie, 32(10):562-6, 2009. (SCI)

A20. Alici S, Çoşkun U, Alkis N, Sevinc A, Dane F, Gumus M, Ozkan M, Kaya AO, Celenkoglu G, Buyukberber S, Altunbas M, Benekli M. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic NSCLC. Asian Pasific J Cancer Prev, 10:1051-55, 2009SCI-E

A21. Karaoglu A, Arslan UY, Ozkan M, Kalender ME, Alici S, Coskun U, Gumus M, Celenkoglu G, Er O, Sevinc A, Buyukberber S, Alkis N, Benekli M; Anatolian Society of Medical Oncology. Efficacy and toxicity of gemcitabine and pegylated liposomal doxorubicin in recurrent platinum resistant/refractory epithelial ovarian cancer. Asian Pac J Cancer Prev, 10(1): 63-6, 2009,SCI-E

A22. Atmaca AF, Altinova S, Canda AE, Ozcan MF, Alici S, Memis L, Balbay MD. Retroperitoneal extragonadal nonseminomatous germ cell tumor with synchronous orbital metastasis. Adv Urol, . 2009:419059. Epub 2009 Jan 29SCI-E

A23. Atmaca AF, Akbulut Z, Demirci A, Belenli O, Alici S, Balbay DM. Multiple subcutaneous nodular metastases from transitional cell carcinoma of the bladder.
Pathol Oncol Res, 13(1):70-2, (2007).

A24. Alici S, Uğraş S, Bayram İ, İzmirli M. Prognostic Factors and COX-2 Expression in Advanced Stage Esophageal Squamous Cell Carcinoma (ESCC). Advences in Therapy, 23(5):672-9,(2006). SCI-E

A25. Alici S, Bavbek S, Basaran M, Onat H. Prognostic factors in patients with aggressive non-hodgkin lymphoma (nhl) without complete response to first-line therapy Advences in Therapy, 23(4):534-42, (2006).SCI_E

A26. Alici S, Kaya S, İzmirli M, Tuncer T, Doğan E, Ozbek H, Sayarlıoglu H. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit,

12(5):221-9,(2006).SCI-E

A27. Alici S, Bavbek S.E, Basaran M, Onat H. Effect of age characteristics and clinical behavior of adult agressive non-Hodgkin’s lymphoma. Eur J Gen Med, 3(3):93-101, (2006).

A28. Algun E, Kosem M, Alici S, Harman M, Guler O, Kotan C. Malignant pheochromocytoma with peritonitis carcinomatosa. The Endocrinologist, 15(5):286-288, (2005).

A29. Sayarlıoğlu M, İzmirli M, Uzun K, Alici S, Erkoç R. Rheumatoid arthritis and pulmonary carcinoid tumor. Eur J Gen Med, 2(1):35-38, (2005).

A30. Dogan E, Erkoç R, Sayarkıoğlu H, Alici S, Dilek İ. Fatal lactic acidosis due to leukemic transformation in a patient with non-Hodgkin’s lymphoma: case report.
Adv Ther.  Sep-Oct;22(5):443-6, (2005)SCI-E

A31. Doğan E, Izmirli M, Ceylan K, Erkoç R, Sayarlıoğlu H, Alici S. Incidence of renal insufficiency in cancer patients. Adv Ther. Jul-Aug;22(4):357-62, (2005).SCI-E

A32. Ozbek H, Bayram I, Öztürk M, Erdoğan E, Alici S, Uygan İ. Risk of gastrointestinal cancer in mice after consuming salted and dried fish in Van –Ercis region. International Journal of Cancer Research, 1(2):106-108, (2005).

A33. Dülger H, Alıcı S, Algün E, Etlik Ö, Sayarlıoğlu M, Doğan E, Sayarlıoğlu H, Şekeroğlu M.R. Antithyroid antibody levels in patients with breast cancer. Eur J Gen Med, 1(2):11-14, 2004.

A34. Dülger H, Alici S, Şekeroglu MR, Erkoc R, Ozbek H, Noyan T, Yavuz M. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer. Int J Clin Pract, 58(6), 545-549 (2004). SCI

A35. Alici S, Saip P, Eralp Y, Aydiner Y, Topuz E. Oral etoposide (VP16) in platinum-resistent epithelial ovarian cancer (E

OC). Am J Clin Oncol, 26(4), 358-362, (2003). SCI

A36. Alici S, Kosem M, Kotan C. Isolated splenic metastases occurring as an unknown primary lesion. Journal of Postgraduate Medicine, 49(1):83-84, (2003). SCI-E

A37. Alici S, Bavbek SE, Kaytan E, Basaran M, Bulutlar G, Onat H. Survival outcomes in aggressive non-Hodgkin’s lymphoma according to international prognostic index. Journal of BUON, 8(2), 121-126, (2003).

A38. Alici S, Aykan NF, Sakar B, Bulutlar G, Kaytan E, Topuz E. Colorectal cancer in young patients: characteristics and outcome. Tohoku J Exp Med, 199(2), 85-93 (2003).SCI

A39. Algun E, Alici S, Topal C, Ugras S, Erkoc R, Sakarya ME, Ozbey N. Coexistence of subacute thyroiditis and renal cell carcinoma: a paraneoplastic syndrome. CMAJ, 168(8), 985-986 (2003).SCI

A40. Alici S, Bavbek SE, Kaytan E, Eralp Y, Onat H. Prognostic factors in localized aggressive non-Hodgkin’s lymphoma. Am J Clin Oncol, 26(1), 1-5 (2003).SCI

A41. Kotan C, Kösem M, Alici S, Ilhan M, Tuncer I, Harman M. Primary malignant fibrous histiocytoma of the small intestine presenting as an intussusception: report of a case. Surg Today, 32(12), 1091-1095 (2002).SCI-E

A42. Dulger H, Sekeroglu MR, Eryonucu B, Noyan T, Alici S. The effect of high dose digoxin on cytokines in healthy dogs. Mediators Inflamm, 11(4), 261-263 (2002). SCI

A43. Alici S, Bavbek SE, Kaytan E, Basaran M, Eralp Y, Onat H. Aggressive non-Hodgkin’s lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostics factors. Am J Clin Oncol, 25(5), 502-508 (2002).SCI

A44. Alici S, Eralp Y, Saip P, Argon A, Basaran M, Topuz E, Aydiner A. Clinical charactesistics of gestational trophoblastic disease at a single institute. Tohoku J Exp Med, 197(2), 95-100 (2002).SCI

A45. Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E. Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol, 25(4), 371-379 (2002).SCI

A46. Alici S, Bavbek S.E, Eralp Y, Argon A, Basaran M, Aydiner A, Tuzlali S, Topuz E, Onat H. An atypical presentation of metastatic gestational choriocarcinoma with maxillary

sinus and subcutaneous involvement; report of a case with literature review. Journal of BUON, 7, 373-376 (2002).

A47. Alici S, Özen S, Kotan Ç. Small cell carcinoma of the esophagus: report of a case with review of the literature. Journal of BUON, 7, 161-164 (2002).

A48. Kaytan E, Karadeniz A, Alici S, Fayda M, Kizir A. Unusual metastases from rectal adenocarcinoma; report of two cases with literature rewiev. Journal of BUON, 7, 377-380 (2002).

A49. Basaran M, Bavbek ES, Sakar B, Eralp Y, Alici S, Tas F, Yaman F, Dogan OO, Camlica H, Onat H. Treatment of aggressive non-Hodgkin’s lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study. Am J Clin Oncol, 24(6), 570-575 (2001).SCI

A50. Tas F, Aykan F, Alici S, Kaytan E, Aydiner A, Topuz E. Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease. Am J Clin Oncol, 24(6), 547-550 (2001).SCI

B. Papers presented at international scientific meetings published in proceedings B1-34:

B1. Kaplan M.A, Isıkdogan A, Koca D, Kucukoner M, Gumusay O, Yıldız R, Oztop I, Demir L, Geredeli C, Kocer M, Arslan U.Y, Inal A, Coskun U, Sener N, Inanc M, Elkıran E.T, Ozdemir N, Durnalı A.G, Suner A, Alıcı S. Lapatinib or trastuzumab? Which anti-Her2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study. ASCO A93589, Chicago 2012

B2. Alici S, Alici O, İzmirli M, Tunahan H, Gercik F, Beğenik H. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for solid tumors. 43rd ASCO Annual Meeting Proceeding June 1-5, Chicago, P19611, 2007

B3. Alici S, Bavbek S, Basaran M, Onat H. Prognostic features and outcome in patients with aggressive Non-Hodgkin Lymphoma who do not achieve a complete response to first-line regimens. Journal of Clin. Oncol, 2005 ASCO annual meeting proceedings, Vol 23 NO.16S, Part I of II, 2005:6737.

B4. Dülger H, Alıcı S, Şekeroğlu MR, Noyan T, Yavuz M. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer. Clinical Chemistry and Laboratory Medicine Euromedlab, Barcelona, Spain, W-420,

2003.

B5. Özbek H, Bayram İ, Öztürk M, Erdogan E, Öztürk A, Alıcı S, Uygan İ, Kösem M. Investigation of gastrointestinal cancer inducing risk of concumption of salted fish in Van –Erciş region: a one-year-long animal study. 5th International Congress of Turkish Society of Toxicology, Antalya, P-122, 2003.

B6. Alici S, Aykan F, Sakar B, Bulutlar G, Kaytan E, Eralp Y. Comparison of some clinical and histological features of colorectal carcinoma occurring in patients <=40 years and >40 years of age. Fourth International Conference: Perspectives in Colorectal Cancer: a consensus meeting, Barcelona, Spain, A14, 2002.

B7. Alici S, Bavbek S.E, Kaytan Y, Eralp Y, Argon A, Onat H. Prognostic factors in localized aggressive non-Hodgkin’s lymphoma. American Society of Clinical Oncology: Thirty-Eighth annual Meeting, Orlando, FL, Vol. 21, A2641, 2002.

B8. Sakar B, Basaran M, Argon A, Alici S, Eralp Y, Kaytan E, Bugra D, Aykan F.N, Topuz E. The link between local recurrence and survival in patients with primary rectal cancer. American Society of Clinical Oncology: Thirty-Eighth annual Meeting, Orlando, FL, Vol. 21, A2372, 2002.

B9. Kotan C, Ozen S, Alici S, Kosem M, Tuncer I, Ilhan M, Arslan M. Primary lymphoma and adenocarcinoma of the appendix. (Case reports and review of the literature) 11th World Congress of the International Association of Surgeons & Gastroenterologist, Hepato-Gastroenterology: Current Medical and Surgical Trends, Greece, Vol. 48, supplement 1, P-179, 2001.

B10. Aksoy H, Ozbek H, Turkdogan K, Algun E, Dilek I, Tuncer I, Ugras S, Erkoc R, Sayarlioglu M, Alici S, Ilhan M, Sahin I, Memik F. Is herby cheese ulcerogenic? 11th World Congress of the International Association of Surgeons & Gastroenterologist, Hepato-Gastroenterology: Current Medical and Surgical Trends, Greece, Vol. 48, supplement 1, P-99, 2001.

B11. Kotan C, Kosem M, Alici S, Ilhan M, Tuncer I, Harman M. Primary malignant fibrous histiocytoma of the small intestine presenting as an intussusception. 11th World Congress of the International Association of Surgeons & Gastroenterologist, Hepato-Gastroenterology: Current Medical and Surgical Trends, Greece, Vol. 48, supplement 1, P-224, 2001.

B12. Alici S, Kotan C, Kosem M, Mercan R. Metastatic splenic cancer occurring as an unknown primary lesion. 11th World Congress of the International Association of Surgeons & Gastroenterologist, Hepato-Gastroenterology: Current Medical and Surgical Trends, Greece, Vol. 48, supplement 1, P-196, 2001.

B13. Algun E, Alıcı S, Topal C, Ugraş S, Erkoç R, Sakarya ME, Özbey N. Coexistence of subacute thyroiditis and renal cell carcinoma: a para-neoplastic syndrome? The 24th Congress of Endocrinology and Metabolic diseases of Turkey Joint Meeting with The American Association of Clinical Endocrinologist, Endocrine practice, supplement for September/October, P21, 2001.

B14. Dulger HH, Sekeroglu MR, Noyan T, Alici S, Eryonucu B. The early effect of high doses of digoxin on the cytokines. 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine 5th Czech National Congress of Clinical Biochemistry, Clinical Chemistry and Laboratory Medicine, Prague, Vol. 39, special supplement  PO-G017, 2001.

B15. Aydiner A, Alici S, Karnap M, Uygun K, Karadeniz A, Topuz E. Synchronous internal cancers in patients with primary squamous or basal cell skin carcinoma. American Society of Clinical Oncology, Thirty-Seventh Annual Meeting, San Francisco, CA, Vol. 20, P3089, 2001.

B16. Aykan F.N, Argon A, Alici S, Bulutlar G. A phase II trial of gemcitabine in patients with advanced pancreatic cancer (APC). American Society of Clinical Oncology, Thirty-Sixth Annual Meeting, New Orleans, LA, Vol. 19, P1241, 2000.

B17. Alici S, Bulutlar G, Saip P, Eralp Y, Aydiner A, Topuz E. Oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease. 10th International Congress on Anti-Cancer Treatment, Paris, France, AB013, 2000.

B18. Alici S, Kaytan E, Basaran M, Bavbek SE, Darendeliler E, Onat H. Effect of age on the characteristics and clinical behavior of non-Hodgkin’s lymphoma (NHL) patients (pts). American Society of Clinical Oncology, Thirty-Sixth Annual Meeting, New Orleans, LA, Vol. 19, P146, 2000.

B18. Alici S, Kaytan E, sakar B, Bulutlar G, Eralp Y, Argon A, Aykan NF. Rectal cancer in young patients: Characteristics and outcome. Abstract Book of the 25th European Society for Medical Oncology (ESMO) Congress, Annals of Oncology, Hamburg, Germany, Vol. 11, supplement 4, P245, 2000.

B20. Aykan NF, Alici S, Argon A, Bulutlar G, Sakar B. Irinotecan (CPT-11) as first, second and third-line chemotherapy in advanced colorectal cancer (CRC) resistant to fluorouracil (5-FU). 1st European congress on Gastrointestinal Oncology, Annals of Gastroenterology, Island of Kos, Greece, Vol. 13, supplement 1, P125, 2000.

B21. Erkoc R, Aksoy H, Ilhan M, Dulger H, Sekeroglu R, Tarakcioglu M, Alici S, Sayarlioglu M, Dilek I. Hyperuricemia and various correlated parameters in people of Van city, Turkey. Clin Chem Lab Med, Italy, special supplement 37, W039, 1999.

B22. Alici S, Aydiner A, Eralp Y, Bulutlar G, Altun M, Budak R, Topuz E. An atypical presentation of metastatic choriocarcinoma with maxillary sinus and subcutaneous involvement. Ninth International Congress on Anti-Cancer Treatment, Paris, France, PP16, 1999.

B23. Bavbek SE, Basaran M, Uygun K, Alici S, Darendeliler E, Onat H. Cyclophosphamide, vincristine, epirubicin and prednisolone (ceop-100) in aggressive non-Hodgkin’s lymphoma (ANHL). The European Cancer Conference (ECCO 10), The European Journal of Cancer, Vienna, Vol. 35, Supplement 4, P1356, 1999.

B24. Basaran M, Bavbek SE, Alici S, Uygun K, Dogan O, Agan M, Darendereliler E, Onat H. Prognostic factors in primary gastric non-Hodgkin’s lymphoma. The European Cancer Conference (ECCO 10), The European Journal of Cancer, Vienna, Vol. 35, Supplement 4, P1357.

B25. Topuz E, Alici S, Tas F, Eralp Y, Bulutlar G, Saip P, Aydıner A. Clinical characteristics of gestational trophoblastic disease (GTD) at a single institute. Ninth International Congress on Anti-Cancer Treatment, Paris, France, PP15, 1999.

B26. Alici S, Bavbek SE, Basaran M, Camlıca H, Onat H. Prognostic factors and long term follow-up in aggressive non-Hodgkin’s lymphoma (NHL). American Society of Clinical Oncology 35th Annual Meeting, Atlanta-GA, P143, 1999.

B27. Erkoc R, Uygan I, Topal C, Atilla MK, Alici S, Dilek I, Aksoy H. A case of malignancy associated obstructive uropathy, rapid relief of obstruction with chemotherapy. IVth Congress of Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs, İzmir-Türkiye, p94, 1999.

B28. Erkoc R, Aksoy H, Alici S, Ilhan M, Sayarlioglu M, Dulger H, Uygan I, Avci E. Crossectional population survey for creatinine values and some related parameters in people of Van city, Turkey. European Renal Association, European Dialysis and Transplant Association Annual Congress, Madrid, Spain, Vol. 14n.9, A117, 1999.

B29. Inanc S.E, Alici S, Saip P, Kurul S, Onat H. High–dose ifosfamide in refractory, recurrent and metastatic sarcoma. Abstract Book of the 23th European Society for Medical Oncology (ESMO) Congress, Annals of Oncology, Athens, Greece, Vol. 9, supplement 4, 567P, 1998.

B30. Algün E, Tarakcioglu M, Sekeroglu MR, Alici S, Topal S. Insulin resistance in patients with type 4 hiperlipidaemia. 4th Meeting of The Balkan Clinical Laboratory Federation, Balkan J Clin Lab, Budva, Yugoslavia, Vol. 3, P306, 1996.

B31. Yeksan M, Alıcı S, Polat H, Koşar A, Dalmaz M, Türk S, Çalışkan Ü. Intravenous Iron administration anemic hemodialysis patients who are resistant to rHu-EPO therapy. XXXIst congress of the European Renal Association European Dialysis and transplant Association, Vienna, Austria, p284, 1994.

B32. Yeksan M, Koşar A, Dalmaz M, Tamer N, Türk S, Alıcı S. Resistance to erythropoietin therapy in hemodialysis patients (HP). XXXIst congress of the European Renal Association European Dialysis and transplant Association, Vienna, Austria, 1994.

B33. Yeksan M, Koşar A, Şengil AZ, Dalmaz M, Sünbül M, Duman S, Alıcı S, Kaleli S. Effect of different factors on total lymphocytes T4, T8 lymphocytes and T4:T8 ratio in hemodialysis patients. XXXIst congress of the European Renal Association European Dialysis and Transplant Association, Vienna, Austria, p227, 1994.

B34. Yeksan M, Koşar A, Dalmaz M, Alici S, Karabayraktar A, Türk S, Akgüzel M, Erdoğan Y. Comparison of recombinant human erythropoietin and vitamin E treatment on haematological values in haemodialysis. European Dialysis and Transplant Association-European Renal Association 30th Annual Congress, Nefrology Dialysis Transplantation, Glasgow, UK, Vol. 9, p964, 1993.

C. Articles published in national peer-reviewed journals C1-48:

C1. KARACA, Halit ; GEREDELİ, Cağlayan ; KAPLAN, M. Ali ; DEMİRCİ, Umut ; ALICI, Süleyman ; ARTAC, Mehmet ; ISIKDOGAN, Abdurrahman ; BENEKLİ, Mustafa; BALAKAN, Ozan ; ARPACI, Erkan ; BUDAKOĞLU, Burcin ; UNCU, Dogan ; GÜLER, Tunç; BERK, Veli ; OZKAN, Metin. Efficacy and safety of erlotinib in previously treated advanced non-small cell lung cancer. Uluslararası Hematoloji Onkoloji Dergisi, 2013, 23(1):1-6

C2. Alıcı S, Bavbek S.E, Onat H. Evaluation of demographic characteristics and treatment responses of patients with germ cell tumors aged thirty-five and older. Turkish Medical Journal, 2(2):70-4, 2008

C3. Alıcı Ö, Akbaş E, Alıcı S. Opportunistic infections in cancer patients. Turkish Oncology Journal, 23(3): 153-162, 2008.

C4. Dülger H, İzmirli M, Şekeroğlu  MR, Alıcı S, Özen S, Özcan S. Serum gastrin and insulin-like growth factor (IGF-1) levels in patients with esophageal and gastric cancer. International Journal of Hematology Oncology, 17(3):138-142, (2007).

C5. Alıcı S, İzmirli M, Doğan E. Epidemiological evaluation of cancer patients applying to the Medical Oncology Department of Yüzüncü Yıl University Faculty of Medicine. Turkish Oncology Journal, 21(1), (2006).

C6. Alıcı S, Kaya S, İzmirli M, Tuncer İ, Doğan E, Özbek H, Sayarlıoğlu H. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Turkish Oncology Journal, 20(2):51-61, 2005.

C7. Alıcı S, Alıcı Ö, Sayarlıoğlu H, Doğan E, Tunahan H, Topcu N, Çekici S, Erkoç R, Dilek İ. Our results of febrile neutropenia in patients with solid tumors. Turkish Oncology Journal, 20(3):99-102, (2005).

C8. Doğan E, Alıcı S, Erkoç R, Alıcı Ö, Sayarlıoğlu H, Topal C, Algün E, Dilek İ. Relationship of Anticardiolipin IgG and Anticardiolipin IgM positivity with Anti HCV positivity in hemodialysis patients. Van Medical Journal, 12(3):179-181, (2005).

C9. Yuca K, Çankaya H, Kıroğlu F, Alıcı S, Bozkuş F, Kutluhan A. Primary submandibular gland lymphoma in a patient with ataxia telangiectasia: case presentation. KBB-Forum, 3(2), 51-53 (2004).

C10. Uzun K, Temizöz O, Alıcı S, Bayram İ, Altınöz O, Sezgi C, İşlek A, Özbay B. Small cell lung cancer diagnosed with pancreatic metastasis: Case presentation. 19(4):148-151, (2004).

C11. Uzun K, Alıcı S, İzmirli M, Özbay B, Bayram İ, Altınöz O, Doğan E, Sezgi C, İşlek A. Cyclophosphamide, Etoposide and Cisplatin combined chemotherapy in advanced small cell lung cancer. Journal of Medical Research, 2(2), 27-32 (2004).

C12. Dülger H, Alıcı S, Algün E, Etlik Ö, Sayarlıoğlu M, Dogan E, Sayarlıoğlu H, Şekeroğlu M.R. Antithyroid antibody levels in patients with breast cancer. Eur J Gen Med, 1(2), 11-14 (2004).

C13. Özbek H, Uğraş S, Alıcı S. Protective effect of fennel essential oil on carboplatin-induced hepatotoxicity. Van Medical Journal, 10(4), 91-97 (2003).

C14. Sakarya ME, Alıcı S, Dilek İ, Özen S, Topçu N, Odabaş H. Primary non-Hodgkin lymphoma of the breast: MR findings. Journal of Medical Research, 1(1), 22-24 (2003).

C15. Alıcı S, Kösem M, Kotan Ç. Male breast carcinoma. Turkish Dermatology Journal, 37(2), 117-119 (2003).

C16. Uzun K, Alıcı S, Özbay B, Gencer M, Irmak H. The incidence of hepatitis C virus in patients with lung cancer. Turkish Respiratory Journal, 3(3), 91-93 (2002).

C17. Alıcı S, Algün E, Türkdoğan K, Uğraş S, Dülger H. Celiac disease characterized by malabsorption syndrome, dimorphic anemia, and osteomalacia (Case Presentation). T Klin Gastroenterohepatology, 13(2), 94-98 (2002).

C18. Aksoy H, Erkoç R, Alıcı S, İlhan M, Dilek İ, Türkdoğan K, Sayarlıoğlu M, Topal C. Investigation of important health standards and prevalence of some diseases in adults in Van province: Examination of methodology. Van Medical Journal, 9(3), 78-82 (2002).

C19. Dilek İ, Erkoç R, Sayarlıoğlu M, İlhan M, Alıcı S, Türkdoğan K, Topal C, Durmuş A, Aksoy H. Hemogram and ferritin levels in healthy adult individuals living in central and rural areas of Van province. Van Medical Journal, 9(2), 52-55 (2002).

C20. Dülger H, Alıcı S, Şekeroğlu MR, Noyan T, Yalçınkaya A. Effect of chemotherapy on lipid peroxidation in cancer patients. Van Medical Journal, 9(2), 56-59 (2002).

C21. Alıcı S, Çekici S. The role of bisphosphonates in malignant diseases. Van Medical Journal, 9(2), 66-72 (2002).

C22. Erkoç R, Aksoy H, Alıcı S, İlhan M, Sayarlıoğlu M, Dilek İ, Uygan İ, Topal C, Meral C. Hypertension prevalence in Van, Turkey-1997. Eastern Journal of Medicine, 6(1), 22-25 (2001).

C23. Kotan Ç, Özen S, Alıcı S, Kösem M, Tuncer İ, İlhan M, Arslan M. Primary lymphoma and adenocarcinoma of the appendix. Colon Rectum Disease Journal, 11, 60-65 (2001).

C24. Alıcı S, Dülger HH. Nonenzymatic glycosylation of hemoglobins. Van Medical Journal, 8(3), 105-109 (2001).

C25. Uygun K, Başaran M, Bavbek E.S, Eralp Y, Taş F, Alıcı S, Şakar B, Onat H. Low mortality risk in the treatment of febrile neutropenia in patients with solid tumors. Turkish Oncology Journal, 15(3), 108-111 (2000).

C26. Herken H, Aşkın R, Karaca S, Doğan E, Yeksan M, Türk S, Alıcı S. Psychiatric symptom levels and coping methods in dialysis patients. Anadolu Medical Journal, 3:206-211, (2000).

C27. Algün E, Şekeroğlu R, Erkoç R, Özbek H, Alıcı S, İlhan M, Mete R, Aksoy H. Investigation of various atherosclerotic risk factors in healthy volunteers who smoke and the effect of low-dose ACE inhibitor usage on these parameters. Van Medical Journal, 6(3), 10-14 (1999).

C28. Vural H, Sabuncu T, Alıcı S, Türk S. Glucose tolerance and lipid profile in survivors of myocardial infarction. Eastern Journal of Medicine, 4(2), 51-53 (1999).

C29. Türkdoğan M.K, Alıcı S, İlhan M, Dilek H, Akman E, Ayakta H, Karakök M. Helicobacter pylori infection in gastric carcinoma in the Van region of Turkey. Turkish Journal of Gastroenterology, 10(1), 36-39 (1999).

D30. Alıcı S, Algün E, İlhan M, Aksoy H. Pseudothrombocytopenia in the differential diagnosis of thrombocytopenia (Case Presentation). T Klin Medical Sciences, 18, 64-65 (1998).

D31. Uzun K, Özbay B, Alıcı S. Diuretics in human asthma. T Klin J Med Sci, 17, 365-368 (1997).

D32. Aksoy H, Alıcı S. Thyroid nodules: general characteristics and diagnostic methods. Van Medical Journal, 4(3), 187-192 (1997).

D33. Tarakçıoğlu M, Algün E, Şekeroğlu R, Alıcı S, Topal S, Meral İ. Thyroid hormone levels in hemodialysis patients and the effect of a hemodialysis session on these values. Van Medical Journal, 4(4), 201-204 (1997).

D34. Alıcı S, Vural H, Ecirli Ş. HbA1c and fructosamine values in iron deficiency anemia. Turkey Medical Journal, 4(6), 371-375 (1997).

C35. Alıcı S, Uzun K, Türk S, Bayram A. Cardiac metastasis: evaluation of 40 cases. Turkey Medical Journal, 4(5), 345-347 (1997).

C36. Alıcı S, Algün E, Akdeniz H, Aksoy H. Neurobrucellosis (case presentation). Clinical Sciences & Doctor, 3(2):189-190, (1997).

C37. Dura S, Ecirli Ş, Alıcı S, Polat H, Can G. Prevalence of iron deficiency anemia among students of Selçuk University Faculty of Medicine. S.U. Medical Faculty Journal, 12(4), 383-388 (1996).

C38. Gökbel H, Üçok K, Alıcı S, Kaptanoğlu B. Use of recombinant erythropoietin in anemia of chronic kidney failure. Syndrome, April, 60-64 (1996).

C39. Tarakçıoğlu M, Şekeroğlu M.R, Kara M, Algün E, Tuncer İ, Alıcı S, Aslan R, Akman N. The effect of age and sex on serum lipid levels in healthy individuals. Van Medical Journal, 3(1), 34-40 (1996).

C40. Dalmaz M, Yeksan M, Sağmanlıgil N, Koşar A, Alıcı S, Türk S. Use of calcium carbonate-magnesium carbonate as a phosphorus binder in hemodialysis patients. Drug and Treatment Journal, 9(9), 553-557 (1996).

C41. Uzun K, Özbay B, Erkoç R, Gencer M, Alıcı S. The effect of hemodialysis on respiratory function tests in patients with chronic renal failure. Van Medical Journal, 3(3-4), 158-161 (1996).

C42. Vural H, Akkuş İ, Koç A, Alıcı S, Çağlayan O, Durmuş B. Monitoring of intracellular 2,3-bisphosphoglycerate (2,3-BPG) and ATP levels in alcoholic individuals. T Klin Medical Sciences Journal, 15, 354-356 (1995).

C43. Koşar A, Sünbül M, Saniç A, Alıcı S. Positivity of HBs antigen (HbsAg) and antibodies (anti-HBs) in medical students and health personnel. Microbiology Bulletin, 29, 52-57 (1995).

C44. Polat H, Alıcı S, Dalmaz M, Aslan U, Sünbül M. Comparison of IM diclofenac sodium and IV dipyrone/spasmolytic combination in the treatment of renal colic. Rheumatism and Pain Bulletin, 2(2), 28-29 (1995).

C45. Baykan M, Koşar A, Yeksan M, Türk S, Alıcı S, Polat H, Dalmaz M. HCV and CMV prevalence in our hemodialysis unit over the last 5 years. Journal of Turgut Özal Medical Center, 2(2), 152-154 (1995).

C46. Kaptanoğlu B, Dalmaz M, Koşar A, Yeksan M, Akkuş İ, Yeksan N, Alıcı S. r-HuEPO therapy and serum total glutathione s-transferase activity. Journal of Turgut Özal Medical Center, 2(1), 28-31 (1995).

C47. Polat H, Alıcı S, Kaptanoğlu B, Koşar A, Akgüzel M, Korkut B, Türk S, Bayram A. The effect of nitrendipine on blood pressure, pulse rate, blood lipids, blood glucose, creatinine clearance, and liver enzymes in patients with essential hypertension. Central Anatolia Medical Journal, 4(2), 157-161 (1994).

C48. Karaköse S, Kaya A, Çakır A.İ, Alıcı S. Effect of metoclopramide on gallbladder function in diabetic patients with autonomic neuropathy. U E D, 4(4), 195-202 (1994).

D. Papers presented at national scientific meetings published in proceedings D1-73

D1. Ünal O.Ü, Öztop İ, Yazıcı O, Uncu D, İnal A, Günaydın Y, Nuriye Ö, Alıcı S, Demirci U, Çınkır H.Y, Yılmaz U. Primary peritoneal serous carcinomas: A different clinical entity (ATOD STUDY). 4th National Gastrointestinal Oncology Congress, Antalya, Oral Presentation Page 1, 2012.

D2. Karaca H, Ozkan M, Demirci U, Ozdemir NY, Kücüköner M, Berk V, Arslan Ü.Y, Sönmez Ö.U, Benekli M, Uncu D, Işıkdogan A, Ustaalioğlu B.Ö, Çolak D, Alıcı S. Gastroenteropancreatic neuroendocrine tumor database: ATOD study. 3rd National Gastrointestinal Oncology Congress, Antalya, Oral Presentation 31, 2011.

D3. Çiltaş A, Koca D, Yılmaz U, Buyukberber S, İnal A, Oztop İ, Binicier Ç, Köş T, Işıkdoğan A, Özdemir N, Eşbah O, Alıcı S, Balakan O, Çoşkun U, Benekli M. Retrospective evaluation of the effectiveness and tolerability of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: ATOD study. 3rd National Gastrointestinal Oncology Congress, Antalya, Presentation 62, 2011.

D4. İnal A, Öztürk S.C, İnanc M, Geredeli Ç, Alıcı S, Harputluoğlu H, Çolak D, Sönmez Ö.U, Balakan O, Doğu G.G, Göksel G, Işıkdoğan A. Breast cancer cases in elderly patients: Tumor characteristics (ATOD study). VIII. National Medical Oncology Congress, Mugla, Presentation 9, 2011.

D5. Kaya A.O, Özkan M, Sevinç A, Yılmaz A.U, Gümüş M, Ünal O.Ü, Özdemir N.Y, Camcı C, Alıcı S, Berk V, Değerli H, Öner M.K, Kefeli U. Retrospective evaluation of the efficacy of the combination of paclitaxel-adriamycin in advanced urothelial type bladder cancer (ATOD study). VIII. National Medical Oncology Congress, Mugla, Presentation 13, 2011.

D6. Karaca H, Özkan M, Ulaş A, Demirci U, Özdemir N.Y, Berk V, Sönmez Ö.U, Kücüköner M, Alkış N, Uncu D, Doğu G.G, Balakan O, Çolak D, Ustaalioğlu B.Ö, Alıcı S, Büyükberber S. Neuroendocrine tumor database: Multicenter retrospective evaluation (Updated ATOD study). VIII. National Medical Oncology Congress, Mugla, Presentation 44, 2011.

D7. Karaca H, Geredeli Ç, Kaplan M.A, Demirci U, Alıcı S, Börüban M.C, Işıkdoğan A, Benekli M, Balakan O, Arpacı E, Budakoğlu B, Uncu D, Güler T, Özkan M. Evaluation of the efficacy and side effect of erlotinib treatment in patients with non-small cell lung cancer (ATOD Study). VIII. National Medical Oncology Congress, Mugla, Presentation 43, 2011.

D8. Kaplan A, Işıkdoğan A, Koca D, Bostankolu Ö, Aslan Y. Ü, İnanç M, Yaman Ş, Durnalı A, Alıcı S, Küçüköner M, Çoşkun U, İnal A, Yılmaz U, Büyükberber S. Contribution of systemic therapy to survival in patients with breast cancer developing brain metastasis according to histological subtypes VIII. National Medical Oncology Congress, Mugla, Presentation 102, 2011.

D9. Balakan O, İnanç M, Sevinç A, Özkan M, Alıcı S, Camcı C. Retrospective evaluation of the data of liposomal doxorubicin (Modified CALYPSO) in recurrent epithelial ovarian cancer. VIII. National Medical Oncology Congress, Mugla, Presentation 121, 2011.

D10. Baykara M, Özdemir N, İnaç M, Ünal O.Ü, Eşbah O, Arpacı E, Alıcı S, Uncu D, Benekli M, Özkan M, Akman T, Öksüzoğlu B, Alkış N, Coşkun U, Aksoy S, Karaca H, Salman T, Geredeli Ç, Büyükberber S. Extrapulmonary small cell carcinomas: A different clinical entity from small cell lung carcinomas. VIII. National Medical Oncology Congress, Mugla, Presentation 169, 2011.

D11. Çetin B, Berk V, Geredeli Ç, Küçükönder M, Öksüzoğlu B, Özkan M; Güler T, Göksel G, Işıkdoğan A, Büyükberber S, Uncu D, Alıcı S, Çoşkun U, Benekli M. Combination of cisplatin and gemcitabine in biliary tract cancers. VIII. National Medical Oncology Congress, Mugla, Presentation 191, 2011.

D12. Alıcı S, Büyükberber S, Demirci U, Özkan M, Alkış N, Karaca H, Benekli M, Arpacı E, Dikilitaş M, Altınbaş M, Dane F, Coşkun U, Paksoy F, Yıldız R. VII. National Medical Oncology Congress, Antalya Poster S:77, 2010.

D13. Altın baş M, Kalender M.E, Sevinç A, Camcı C, Alıcı S, Alkış N, Yıldız R, Çolak D, Uncu D, Arpacı E. Initial analysis of patients with relapsed small cell lung cancer receiving topotecan-retrospective (ATOD Study). 6th National Medical Oncology Congress, Antalya B:62, 2009.

D14. Alıcı S, Büyükberber S, Özkan M, Demirci U, Alkış N, Altınbaş M, Benekli M, Berk V, Paksoy F, Çoşkun U. Application of docetaxel 60-cisplatin 60 and 46-hour infusional 5-FU (modified DCF) in advanced gastric cancer. 6th National Medical Oncology Congress, Antalya B:04, 2009.

D15. Alıcı S, Çoşkun U, Alkış N, Sevinç A, Dane F, Gümüş M, Özkan M, Kaya A. O, Çelenkoğlu G, Büyükberber S, Altınbaş M, Benekli M. Vinorelbine as consolidation therapy after vinorelbine-carboplatin combination in advanced non-small cell lung cancer. 6th National Medical Oncology Congress, Antalya B:64, 2009.

D16. Alıcı S, Kasar M. Frequency of venous thrombosis in cancer patients and determination of levels of antithrombin III, protein C, protein S. IV National Medical Oncology Congress, Antalya B36, 2007.

D17. Alıcı S, Beğenik H, İzmirli M, Öztürk Ü, Soyaral Y, Akbaş E, Aksu N. Our results of adjuvant chemoradiotherapy in patients with operated gastric adenocarcinoma and prognostic factors. IV National Medical Oncology Congress, Antalya B32, 2007.

D18. Alıcı S, Akbaş E, Aksu N. Testicular liposarcoma: case presentation. IV National Medical Oncology Congress, Antalya B63, 2007.

D19. Alıcı O, Alıcı S, Beğenik H, Gerçik F, Tunahan H. Frequency of hepatitis virus infection and liver dysfunction in patients with solid tumors. I. Medical Oncology Congress, March 29-April 2, Antalya, S 22, 2006.

D20. İlhan M, Atmaca M, Esen R, Yardım H, Efe M, Alıcı S. Descriptive characteristics of esophageal cancers in the Van region: analysis of 179 cases. XVI. National Cancer Congress, April 20-24 Antalya, S 27, 2005.